[
  {
    "ts": "2026-01-29T03:03:28+00:00",
    "headline": "Earnings To Watch: Regeneron (REGN) Reports Q4 Results Tomorrow",
    "summary": "Biotech company Regeneron (NASDAQ:REGN) will be reporting earnings this Friday before market open. Here’s what investors should know.",
    "url": "https://finance.yahoo.com/news/earnings-watch-regeneron-regn-reports-030328429.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "a96b00db-c230-3fdc-8829-4e87c0bf9e42",
      "content": {
        "id": "a96b00db-c230-3fdc-8829-4e87c0bf9e42",
        "contentType": "STORY",
        "title": "Earnings To Watch: Regeneron (REGN) Reports Q4 Results Tomorrow",
        "description": "",
        "summary": "Biotech company Regeneron (NASDAQ:REGN) will be reporting earnings this Friday before market open. Here’s what investors should know.",
        "pubDate": "2026-01-29T03:03:28Z",
        "displayTime": "2026-01-29T03:03:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/863b7649ab1334021118a8518d7e40cd",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "REGN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E5YeVaDzgHlFxvDwMx9gpg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/863b7649ab1334021118a8518d7e40cd.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6HLp77Q1Eazwpb8zaGf6Xg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/863b7649ab1334021118a8518d7e40cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/earnings-watch-regeneron-regn-reports-030328429.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/earnings-watch-regeneron-regn-reports-030328429.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T08:00:00+00:00",
    "headline": "Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg",
    "summary": "REYKJAVIK, ICELAND (January 29, 2026) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all remaining patent disputes worldwide related to Alvotech’s biosimilar to Eylea® 2mg (aflibercept 40 mg/mL solution), which is approved for marketing in the European Economic Area, United Kingdom a",
    "url": "https://finance.yahoo.com/news/alvotech-secures-settlement-agreement-global-080000240.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "02609a04-2678-3159-a76e-e106387c53c5",
      "content": {
        "id": "02609a04-2678-3159-a76e-e106387c53c5",
        "contentType": "STORY",
        "title": "Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg",
        "description": "",
        "summary": "REYKJAVIK, ICELAND (January 29, 2026) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all remaining patent disputes worldwide related to Alvotech’s biosimilar to Eylea® 2mg (aflibercept 40 mg/mL solution), which is approved for marketing in the European Economic Area, United Kingdom a",
        "pubDate": "2026-01-29T08:00:00Z",
        "displayTime": "2026-01-29T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/8a0f73734c0720ca8ced92018fd212e7",
          "originalWidth": 1045,
          "originalHeight": 364,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zXNKkkhZMap5mi1BfvNTKw--~B/aD0zNjQ7dz0xMDQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8a0f73734c0720ca8ced92018fd212e7.cf.webp",
              "width": 1045,
              "height": 364,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1ZbnWrzrsTTPjuDyQZ978Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8a0f73734c0720ca8ced92018fd212e7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/alvotech-secures-settlement-agreement-global-080000240.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/alvotech-secures-settlement-agreement-global-080000240.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALVO"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BAYRY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T08:54:38+00:00",
    "headline": "Apple, Oil Earnings, Inflation Data: Still to Come This Week",
    "summary": "Another huge technology company, Apple, is set to post quarterly earnings after results from Tesla, Microsoft and Meta Platforms. Plus, a reading on supplier inflation is due. Here is what to watch: Today ...",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-29-2026/card/apple-oil-major-earnings-inflation-data-still-to-come-this-week-qi2FrCsHwtTnempKUUh6?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "01eae514-3639-363c-a7f4-ca7c35c44b3b",
      "content": {
        "id": "01eae514-3639-363c-a7f4-ca7c35c44b3b",
        "contentType": "STORY",
        "title": "Apple, Oil Earnings, Inflation Data: Still to Come This Week",
        "description": "",
        "summary": "Another huge technology company, Apple, is set to post quarterly earnings after results from Tesla, Microsoft and Meta Platforms. Plus, a reading on supplier inflation is due. Here is what to watch: Today ...",
        "pubDate": "2026-01-29T08:54:38Z",
        "displayTime": "2026-01-29T08:54:38Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/01eae514-3639-363c-a7f4-ca7c35c44b3b/apple-oil-earnings-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/a607a96bd5966f226a367f499b46092f",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3VSRRZYw0hizNHvssSur.A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/a607a96bd5966f226a367f499b46092f.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G1Cu_FR4NZKQD6u8wHR4uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/a607a96bd5966f226a367f499b46092f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-29-2026/card/apple-oil-major-earnings-inflation-data-still-to-come-this-week-qi2FrCsHwtTnempKUUh6?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "AXP"
            },
            {
              "symbol": "CVX"
            },
            {
              "symbol": "XOM"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "VZ"
            },
            {
              "symbol": "CAT"
            },
            {
              "symbol": "CMCSA"
            },
            {
              "symbol": "LMT"
            },
            {
              "symbol": "MA"
            },
            {
              "symbol": "NSC"
            },
            {
              "symbol": "V"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T08:00:00+00:00",
    "headline": "Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg",
    "summary": "REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all remaining patent disputes worldwide related to Alvotech’s biosimilar to Eylea® 2mg (aflibercept 40 mg/mL solution), which is approved for marketing in the European Economic Area, Un",
    "url": "https://finance.yahoo.com/news/alvotech-secures-settlement-agreement-global-080000283.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "65f75939-169b-3013-9b4c-926d1d5f91c3",
      "content": {
        "id": "65f75939-169b-3013-9b4c-926d1d5f91c3",
        "contentType": "STORY",
        "title": "Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg",
        "description": "",
        "summary": "REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all remaining patent disputes worldwide related to Alvotech’s biosimilar to Eylea® 2mg (aflibercept 40 mg/mL solution), which is approved for marketing in the European Economic Area, Un",
        "pubDate": "2026-01-29T08:00:00Z",
        "displayTime": "2026-01-29T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/8a0f73734c0720ca8ced92018fd212e7",
          "originalWidth": 1045,
          "originalHeight": 364,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zXNKkkhZMap5mi1BfvNTKw--~B/aD0zNjQ7dz0xMDQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8a0f73734c0720ca8ced92018fd212e7.cf.webp",
              "width": 1045,
              "height": 364,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1ZbnWrzrsTTPjuDyQZ978Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8a0f73734c0720ca8ced92018fd212e7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/alvotech-secures-settlement-agreement-global-080000283.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/alvotech-secures-settlement-agreement-global-080000283.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALVO"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BAYRY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]